Prevalence of Nonalcoholic Fatty Liver Disease and Economy
- PMID: 26017679
- DOI: 10.1007/s10620-015-3728-3
Prevalence of Nonalcoholic Fatty Liver Disease and Economy
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is a growing health issue around the world.
Aim: This study is to investigate whether adult prevalence of NAFLD correlates with national economic status.
Methods: Literature search on PubMed database was conducted to identify eligible records fully published before September 2014. Gross national income (GNI) per capita was chosen to evaluate national economic status. Pearson coefficient, linear regression, and unpaired t test were performed in the statistical analyses.
Results: Twenty-one population-based surveys (seven in East Asia, five in South Asia, three in Middle East, and six in Europe) were included. The pooled prevalence of NAFLD was 24.24%, and the global prevalence was positively correlated with GNI per capita (r = 0.4782, P = 0.0283). Europe witnessed a higher prevalence (28.04%) than Middle East (12.95%, P = 0.0092) and East Asia (19.24%, P = 0.0083). Male presented a higher prevalence than female (P = 0.019), especially in Europe (P = 0.0132) and in Caucasians (P = 0.0383). Furthermore, male prevalence and rural prevalence individually were correlated with economic status (r = 0.5725, P = 0.0257 and r = 0.7389, P = 0.0060). Lastly, the urban (23.93%) witnessed a higher prevalence than the rural or the urban + rural (12.65%, P = 0.0141) in the countries of GNI per capita <$10,000.
Conclusions: This study suggested that countries with higher economic status tend to present a higher prevalence of NAFLD. It is believed to provide a distinctive epidemiologic perspective to global situation of NAFLD.
Keywords: Economy; Epidemiology; Gross national income (GNI) per capita; Nonalcoholic fatty liver disease (NAFLD); Prevalence.
Similar articles
-
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. Hepatology. 2016. PMID: 27543837
-
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14. Clin Liver Dis. 2016. PMID: 27063264 Review.
-
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.Clin Liver Dis. 2018 Feb;22(1):1-10. doi: 10.1016/j.cld.2017.08.001. Epub 2017 Oct 14. Clin Liver Dis. 2018. PMID: 29128049 Review.
-
Global incidence and prevalence of nonalcoholic fatty liver disease.Clin Mol Hepatol. 2023 Feb;29(Suppl):S32-S42. doi: 10.3350/cmh.2022.0365. Epub 2022 Dec 14. Clin Mol Hepatol. 2023. PMID: 36517002 Free PMC article. Review.
-
Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study.BMJ Open. 2020 Aug 3;10(8):e036663. doi: 10.1136/bmjopen-2019-036663. BMJ Open. 2020. PMID: 32747349 Free PMC article.
Cited by
-
Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.Endocrine. 2016 Jan;51(1):91-100. doi: 10.1007/s12020-015-0735-2. Epub 2015 Sep 11. Endocrine. 2016. PMID: 26362060
-
High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease.Sci Rep. 2024 Aug 22;14(1):19541. doi: 10.1038/s41598-024-70645-7. Sci Rep. 2024. PMID: 39174636 Free PMC article.
-
Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study.BMJ Open. 2021 Dec 15;11(12):e056260. doi: 10.1136/bmjopen-2021-056260. BMJ Open. 2021. PMID: 34911725 Free PMC article.
-
Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.BMC Public Health. 2018 May 11;18(1):617. doi: 10.1186/s12889-018-5548-9. BMC Public Health. 2018. PMID: 29751750 Free PMC article.
-
Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit?J Clin Med. 2023 Jun 12;12(12):4001. doi: 10.3390/jcm12124001. J Clin Med. 2023. PMID: 37373694 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical